Netherlands - Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale
Since 2014, Netherlands Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale fell by 13.4% year on year. At €62,791,131.78 in 2019, the country was ranked number 9 among other countries in Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale. Netherlands is overtaken by Croatia, which was ranked number 8 at €79,001,763.77 and is followed by Poland at €51,366,842.93. Denmark ranked the highest with €3,801,340,964.3 in 2019, a fall of 2.9% versus 2018. Belgium, Italy and Germany respectively ranked number 2, 3 and 4 in this ranking. Italy witnessed the best average annual growth at +51.7% per year, while Netherlands recorded the worst performance at -13.4% per year.
Loading...
Date | Euros |
---|---|
2019 | 62,791,131.78 |
2018 | 68,364,000.00 |
2017 | 90,092,000.00 |
2016 | 64,156,000.00 |
2015 | 91,230,000.00 |
How does Netherlands rank in Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale?
# | 16 Countries | Euros | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Denmark
|
3,801,340,964.30 | 2019 | -2.9 % | +26.5 % | View data | |
2 |
#2
Belgium
|
1,624,727,500.00 | 2018 | +46.2 % | NA | View data | |
8 |
#8
Croatia
|
79,001,763.77 | 2019 | +0.8 % | +7.0 % | View data | |
9 |
#9
Netherlands
|
62,791,131.78 | 2019 | -8.2 % | -13.4 % | View data | |
10 |
#10
Poland
|
51,366,842.93 | 2019 | -7.0 % | +5.1 % | View data |